Public Sector Pension Investment Board (PSP Investments)
SCMP

Public Sector Pension Investment Board (PSP Investments)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,752
Closed -$283K – 1497
2017
Q4 		$283K Hold
15,752
– – ﹤0.01% 1353
2017
Q3 		$186K Buy
15,752
+2,952
+23% +$33.1K ﹤0.01% 1366
2017
Q2 		$134K Sell
12,800
-4,200
-25% -$42.8K ﹤0.01% 1266
2017
Q1 		$187K Buy
+17,000
New +$197K ﹤0.01% 1256

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s SCMP Position: Q1 2018 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 15,752 shares — an estimated $283K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $283K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 15,752 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $283K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Sucampo Pharmaceuticals, Inc. position peaked at $283K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2018, filed 10 May 2018.